Treace Medical Concepts TMCI
NASDAQ TMCI
$4.35 -0.21 (-4.61%)
At close: Aug 20, 2026 · 1:15 PM UTC

Treace Medical Concepts (TMCI) Preferred Dividend Payments (2020 - 2021)

Treace Medical Concepts' (TMCI) quarterly Preferred Dividend Payments came in at $39000.0 in Q2 2021, down 75.47% YoY from $159000.0 in Q2 2020, and down 75.32% on a QoQ basis from $158000.0 in Q1 2021.

Treace Medical Concepts (TMCI) Preferred Dividend Payments (2020 - 2021) Analysis & Trends

Treace Medical Concepts (TMCI) has 2 years of Preferred Dividend Payments data on file, last reported at $39000.0 in Q2 2021.

  • Quarterly Preferred Dividend Payments fell 75.47% year-over-year to $39000.0 in Q2 2021, while the trailing twelve-month figure through Jun 2022 was $39000.0 (down 92.49% YoY) and the FY2021 annual result came in at $196000.0, down 69.38% from the prior year.
  • Preferred Dividend Payments retreated to $39000.0 in Q2 2021, from $158000.0 in the prior quarter.
  • In the past five years, Preferred Dividend Payments ranged from a high of $161000.0 in Q3 2020 to a low of $39000.0 in Q2 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Pref Dividends (Qtr)
1 Abbott Laboratories 198.95 Bn 193.35 Bn 7.27 Bn -
2 Stryker 128.10 Bn 124.63 Bn 4.50 Bn -
3 Medtronic 118.91 Bn 109.69 Bn 6.41 Bn -
4 Boston Scientific 73.43 Bn 72.89 Bn 3.85 Bn -
5 Edwards Lifesciences 51.91 Bn 47.66 Bn 1.35 Bn -
6 Dexcom 34.52 Bn 32.58 Bn 830.00 Mn -
7 GE HealthCare Technologies 33.94 Bn 31.83 Bn 2.18 Bn -
8 Koninklijke Philips 26.37 Bn 23.05 Bn 4.55 Bn -
9 Steris 23.14 Bn 22.66 Bn 684.20 Mn -
10 Treace Medical Concepts 282.97 Mn 237.35 Mn 35.61 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2021 39,000.00
Mar 31, 2021 158,000.00
Dec 31, 2020 161,000.00
Sep 30, 2020 161,000.00
Jun 30, 2020 159,000.00
Mar 31, 2020 158,000.00